 |
Director Center for Vaccine Development and Global Health, United States |
|
Dr. Kathleen Neuzil is the Myron M. Levine Professor in Vaccinology, Professor of Medicine and Pediatrics, and the Director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine. She is an internationally recognized research scientist and advocate in the field of vaccinology. Throughout her career, Dr. Neuzil has conducted clinical and epidemiologic studies on vaccine preventable diseases, yielding high-profile publications that inform policy decisions and public health actions. Dr. Neuzil's work has spanned dozens of low-resource countries with multiple vaccines, including influenza, rotavirus, human papillomavirus, Japanese encephalitis, typhoid conjugate vaccines, and most recently, COVID-19 vaccines. Dr. Neuzil was central to the domestic and global response to COVID-19. As a co-PI of the NIH-funded Leadership Group for the Vaccine and Treatment Evaluation Unit network, Dr. Neuzil was part of the strategic team evaluating COVID vaccines and therapeutics in the US and was part of the study team who designed the first COVID-19 clinical vaccine trial in the US. Dr. Neuzil directs TyVAC, the Typhoid Vaccine Acceleration Consortium, with the goal to accelerate the introduction of typhoid conjugate vaccines into low-resource countries. She has more than 300 scientific publications on vaccines and infectious diseases and is a member of the prestigious National Academy of Medicine. Dr. Neuzil's research capabilities are complemented by 20 years of involvement in domestic and international policy, including past membership on the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. She is a member of the World Health Organization Strategic Advisory Group of Experts on Immunization. |
|
| Declarations of Conflict of Interest | |
